These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2439796)
1. Affinity and selectivity of beta-adrenoceptor antagonists in vitro. Wellstein A; Palm D; Belz GG J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S36-40. PubMed ID: 2439796 [TBL] [Abstract][Full Text] [Related]
2. Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay. Wellstein A; Palm D; Belz GG; Leopold G; Bühring KU; Pabst J J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S41-5. PubMed ID: 2439797 [TBL] [Abstract][Full Text] [Related]
3. Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency. Kaumann AJ; Lemoine H Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):27-39. PubMed ID: 2866449 [TBL] [Abstract][Full Text] [Related]
4. Beta-adrenoceptor subtype expression and function in rat white adipocytes. Germack R; Starzec AB; Vassy R; Perret GY Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110 [TBL] [Abstract][Full Text] [Related]
5. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat. D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727 [TBL] [Abstract][Full Text] [Related]
6. The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands. Nanoff C; Freissmuth M; Schütz W Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):519-25. PubMed ID: 2893983 [TBL] [Abstract][Full Text] [Related]
7. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists. Kitagawa Y; Adachi-Akahane S; Nagao T Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230 [TBL] [Abstract][Full Text] [Related]
8. Beta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies. Bundkirchen A; Brixius K; Bölck B; Nguyen Q; Schwinger RH Eur J Pharmacol; 2003 Jan; 460(1):19-26. PubMed ID: 12535855 [TBL] [Abstract][Full Text] [Related]
9. Direct labelling of beta 2-adrenoceptors. Comparison of binding potency of 3H-ICI 118,551 and blocking potency of ICI 118,551. Lemoine H; Ehle B; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):40-51. PubMed ID: 2866450 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the beta-adrenoceptor affinity and selectivity of cetamolol, atenolol, betaxolol, and ICI-118,551. Rimele TJ; Henry DE; Giesa FR; Buckley SK; Geiger G; Heaslip RJ; Lee DK; Grimes D J Cardiovasc Pharmacol; 1988 Aug; 12(2):208-17. PubMed ID: 2459552 [TBL] [Abstract][Full Text] [Related]
11. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium. Sarsero D; Molenaar P; Kaumann AJ Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376 [TBL] [Abstract][Full Text] [Related]
12. Selective labelling of beta 1-adrenoceptors in rabbit lung membranes by (-)[3H]bisoprolol. Wang XL; Brinkmann M; Brodde OE Eur J Pharmacol; 1985 Aug; 114(2):157-65. PubMed ID: 2864272 [TBL] [Abstract][Full Text] [Related]
13. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy. Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characteristics of BDTI, a new isoquinoline-derived beta 2-adrenoceptor agonist, in canine trachea and rat heart. Lin CH; Yang CM; Chen CM; Ko FN; Teng CM Pharmacology; 1996 Jul; 53(1):19-27. PubMed ID: 8875598 [TBL] [Abstract][Full Text] [Related]
15. Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists. Chidlow G; Melena J; Osborne NN Br J Pharmacol; 2000 Jun; 130(4):759-66. PubMed ID: 10864881 [TBL] [Abstract][Full Text] [Related]
16. Studies on the receptor profile of bisoprolol. Klockow M; Greiner HE; Haase A; Schmitges CJ; Seyfried C Arzneimittelforschung; 1986 Feb; 36(2):197-200. PubMed ID: 2870719 [TBL] [Abstract][Full Text] [Related]
17. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes. Sillence MN; Moore NG; Pegg GG; Lindsay DB Br J Pharmacol; 1993 Aug; 109(4):1157-63. PubMed ID: 8104645 [TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptor-binding studies of the cardioselective beta blockers bisoprolol, H-I 42 BS, and HX-CH 44 BS to heart membranes and intact ventricular myocytes of adult rats: two beta 1-binding sites for bisoprolol. Mauz AB; Pelzer H J Cardiovasc Pharmacol; 1990 Mar; 15(3):421-7. PubMed ID: 1691366 [TBL] [Abstract][Full Text] [Related]
19. Radioligand binding characteristics of beta 2-adrenoceptors of cultured melanoma cells. Steinkraus V; Nose M; Mensing H; Körner C Br J Dermatol; 1990 Aug; 123(2):163-70. PubMed ID: 1976019 [TBL] [Abstract][Full Text] [Related]
20. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Baker JG Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]